Department of Radiology
Found 35 results
Filters: Author is de Leon, Mony  [Clear All Filters]
2023
Kelly L, Brown C, Michalik D, Hawkes CA, Aldea R, Agarwal N, Salib R, Alzetani A, Ethell DW, Counts SE et al..  2023.  Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina . Alzheimers Dement.
Zeng X, Wang Z, Tan W, Petersen E, Cao X, LaBella A, Boccia A, Franceschi D, de Leon M, Chiang GChia-Yi et al..  2023.  A conformal TOF-DOI Prism-PET prototype scanner for high-resolution quantitative neuroimaging.. Med Phys.
Agarwal N, Lewis LD, Hirschler L, Rivera LRivera, Naganawa S, Levendovszky SRane, Ringstad G, Klarica M, Wardlaw J, Iadecola C et al..  2023.  Current Understanding of the Anatomy, Physiology, and Magnetic Resonance Imaging of Neurofluids: Update From the 2022 "ISMRM Imaging Neurofluids Study group" Workshop in Rome.. J Magn Reson Imaging.
Mehta NH, Zhou L, Li Y, McIntire LBeth, Nordvig A, Butler T, de Leon M, Chiang GC.  2023.  Peripheral immune cell imbalance is associated with cortical beta-amyloid deposition and longitudinal cognitive decline.. Sci Rep. 13(1):8847.
2022
Chiang GC, Cho J, Dyke J, Zhang H, Zhang Q, Tokov M, Nguyen T, Kovanlikaya I, Amoashiy M, de Leon M et al..  2022.  Brain oxygen extraction and neural tissue susceptibility are associated with cognitive impairment in older individuals.. J Neuroimaging.
Wegiel J, Flory M, Kuchna I, Nowicki K, Wegiel J, Ma SYong, Zhong N, Bobrowicz TWierzba, de Leon M, Lai F et al..  2022.  Developmental deficits and staging of dynamics of age associated Alzheimer's disease neurodegeneration and neuronal loss in subjects with Down syndrome.. Acta Neuropathol Commun. 10(1):2.
Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJelle, Aarsland D, Alcolea D, Altomare D, von Arnim C et al..  2022.  Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.. JAMA Neurol. 79(3):228-243.
Butler T, Chiang GC, Niogi SNarayan, Wang XHugh, Skudin C, Tanzi E, Wickramasuriya N, Spiegel J, Maloney T, Pahlajani S et al..  2022.  Tau PET following acute TBI: Off-target binding to blood products, tauopathy, or both? Front Neuroimaging. 1
2021
Bubu OM, Williams ET, Umasabor-Bubu OQ, Kaur SS, Turner AD, Blanc J, Cejudo JRamos, Mullins AE, Parekh A, Kam K et al..  2021.  Interactive Associations of Neuropsychiatry Inventory-Questionnaire Assessed Sleep Disturbance and Vascular Risk on Alzheimer's Disease Stage Progression in Clinically Normal Older Adults.. Front Aging Neurosci. 13:763264.
Mosconi L, Berti V, Dyke J, Schelbaum E, Jett S, Loughlin L, Jang G, Rahman A, Hristov H, Pahlajani S et al..  2021.  Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition.. Sci Rep. 11(1):10867.
2020
Carare RO, Aldea R, Agarwal N, Bacskai BJ, Bechman I, Boche D, Bu G, Bulters D, Clemens A, Counts SE et al..  2020.  Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA): Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease-Opportunities for. Alzheimers Dement (Amst). 12(1):e12053.
Bubu OM, Umasabor-Bubu OQ, Turner AD, Parekh A, Mullins AE, Kam K, Birckbichler MK, Mukhtar F, Mbah AK, Williams NJ et al..  2020.  Self-reported obstructive sleep apnea, amyloid and tau burden, and Alzheimer's disease time-dependent progression.. Alzheimers Dement.
2019
Reisberg B, Torossian C, Shulman MB, Monteiro I, Boksay I, Golomb J, Benarous FGuillo, Ulysse A, Oo T, Vedvyas A et al..  2019.  Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment).. J Alzheimers Dis. 67(2):685-705.
2018
Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS et al..  2018.  Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.. JAMA Psychiatry. 75(1):84-95.
2017
Wegiel J, Flory M, Kuchna I, Nowicki K, Ma SYong, Wegiel J, Badmaev E, Silverman WP, de Leon M, Reisberg B et al..  2017.  Multiregional Age-Associated Reduction of Brain Neuronal Reserve Without Association With Neurofibrillary Degeneration or β-Amyloidosis.. J Neuropathol Exp Neurol. 76(6):439-457.
Kim H-J, de Leon M, Wang X, Kim HYoung, Lee Y-J, Kim Y-H, Kim SHyun.  2017.  Relationship between Clinical Parameters and Brain Structure in Sporadic Amyotrophic Lateral Sclerosis Patients According to Onset Type: A Voxel-Based Morphometric Study.. PLoS One. 12(1):e0168424.
2016
Kim H-J, Im HKyun, Kim J, Han J-Y, de Leon M, Deshpande A, Moon W-J.  2016.  Brain Atrophy of Secondary REM-Sleep Behavior Disorder in Neurodegenerative Disease.. J Alzheimers Dis. 52(3):1101-9.
Glodzik L, Rusinek H, Kamer A, Pirraglia E, Tsui W, Mosconi L, Li Y, McHugh P, Murray J, Williams S et al..  2016.  Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects.. Alzheimers Dement (Amst). 2:95-104.
2015
Kamer AR, Janal MN, de Leon M.  2015.  Letter to the editor regarding: Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective.. Alzheimers Dement (Amst). 1(4):385-6.
Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FRJ, Visser PJelle, Aalten P, Aarsland D, Alcolea D et al..  2015.  Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.. JAMA. 313(19):1924-38.
Glodzik L, Rusinek H, Li J, Zhou C, Tsui W, Mosconi L, Li Y, Osorio R, Williams S, Randall C et al..  2015.  Reduced retention of Pittsburgh compound B in white matter lesions.. Eur J Nucl Med Mol Imaging. 42(1):97-102.
2014
Glodzik L, Rusinek H, Pirraglia E, McHugh P, Tsui W, Williams S, Cummings M, Li Y, Rich K, Randall C et al..  2014.  Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly.. Neurobiol Aging. 35(1):64-71.
2013
Randall C, Mosconi L, de Leon M, Glodzik L.  2013.  Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.. Front Biosci (Landmark Ed). 18(3):1150-73.
Wadghiri YZaim, Li J, Wang J, Hoang DMinh, Sun Y, Xu H, Tsui W, Li Y, Boutajangout A, Wang A et al..  2013.  Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging.. PLoS One. 8(2):e57097.
Alonso Adel Carmen, ElAkkad E, Gong CX, Liu F, Tanaka T, Kudo T, Tatebayashi Y, Pei JJ, Wang JZ, Khatoon S et al..  2013.  Inge Grundke-Iqbal, Ph.D. (1937–2012): the discoverer of the abnormal hyperphosphorylation of tau in Alzheimer’s disease.. J Mol Neurosci. 49(2):430-5.